PSI Structural Biology Knowledgebase

PSI | Structural Biology Knowledgebase
Header Icons
E-Collection

Related Articles
Design and Evolution: Molecular Sleuthing Reveals Drug Selectivity
June 2015
Families in Gene Neighborhoods
June 2015
Ryanodine Receptor
April 2015
CCR5 and HIV Infection
January 2015
Drug Targets: Bile Acids in Motion
September 2014
Drug Targets: S1R's Ligands and Partners
September 2014
P2Y Receptors and Blood Clotting
September 2014
Bacterial CDI Toxins
June 2014
Glucagon Receptor
April 2014
Viroporins
March 2014
Microbial Pathogenesis: Targeting Drug Resistance in Mycobacterium tuberculosis
February 2014
Design and Discovery: Virtual Drug Screening
January 2014
Cancer Networks: IFI16-mediated p53 Activation
November 2013
G Proteins and Cancer
November 2013
Drug Discovery: Antidepressant Potential of 6-NQ SERT Inhibitors
October 2013
Drug Discovery: Finding Druggable Targets
October 2013
Drug Discovery: Identifying Dynamic Networks by CONTACT
October 2013
Drug Discovery: Modeling NET Interactions
October 2013
Membrane Proteome: GPCR Substrate Recognition and Functional Selectivity
August 2013
Infectious Diseases: Determining the Essential Structome
May 2013
NDM-1 and Antibiotics
May 2013
Microbial Pathogenesis: Computational Epitope Prediction
January 2013
Microbial Pathogenesis: Influenza Inhibitor Screen
January 2013
Microbial Pathogenesis: Measles Virus Attachment
January 2013
Cytochrome Oxidase
November 2012
Membrane Proteome: The ABCs of Transport
November 2012
Bacterial Phosphotransferase System
October 2012
Regulatory insights
September 2012
Solute Channels
September 2012
Pocket changes
July 2012
Receptor bias
July 2012
Anthrax Stealth Siderophores
June 2012
G Protein-Coupled Receptors
May 2012
Substrate specificity sleuths
April 2012
Reading out regioselectivity
December 2011
Superbugs and Antibiotic Resistance
December 2011
Terminal activation
December 2011
A change to resistance
November 2011
Docking and rolling
October 2011
Breaking down the defenses
September 2011
A2A Adenosine Receptor
May 2011
Cell wall recycler
May 2011
Subtly different
March 2011
CXCR4
January 2011
Subtle shifts
January 2011
ABA receptor diversity
November 2010
COX inhibition: Naproxen by proxy
November 2010
Zinc Transporter ZntB
July 2010
Peptidoglycan binding: Calcium-free killing
June 2010
Treating sleeping sickness
May 2010
Bacterial spore kinase
April 2010
Antibiotics and Ribosome Function
March 2010
Safer Alzheimer's drugs?
March 2010
Anthrax evasion tactics
September 2009
GPCR subunits: Separate but not equal
September 2009
Antibiotic target
August 2009
Salicylic Acid Binding Protein 2
August 2009
Lysostaphin
July 2009
Tackling influenza
June 2009
Bacterial Leucine Transporter, LeuT
May 2009
Anthrax stealth molecule
March 2009
Drug targets to aim for
February 2009
High-energy storage system
February 2009
Transporter mechanism in sight
February 2009
Scavenger Decapping Enzyme DcpS
November 2008
Blocking AmtB
September 2008

Research Themes Drug discovery

P2Y Receptors and Blood Clotting

SBKB [doi:10.3942/psi_sgkb/fm_2014_9]
Featured System - September 2014
Short description: PSI researchers have revealed a novel rearrangement in a purine-binding GPCR, opening new avenues for the design of blood clotting drugs.

G-protein-coupled receptors (GPCR) are involved in many aspects of cell communication, and thus are popular targets for many clinical drugs. PSI researchers at the GPCR network have recently reported the structure of an important GPCR target for the development of drugs to block blood clotting, the P2Y12 receptor, which is important for the aggregation of platelets. Several existing anti-clotting drugs bind to this receptor, including clopidogrel (Plavix). The PSI structures will aid in the development of new drugs with better clinical characteristics.

The Same and Different

The P2Y12 receptor, shown here from PDB entry 4pxz, is similar to other GPCRs, with the characteristic bundle of seven alpha helices extending up and down through the membrane. There are a few interesting differences, however. For instance, the fifth helix (seen here at the center in green) is kinked at the center in other GPCRs, but is long and straight in P2Y12. Also, as described in more detail below, the effector binding site is completely buried, surrounded by loops that close around the bound ligand (shown in magenta).


Engineered for Success

To solve the structure of the P2Y12 receptor, PSI researchers continued their successful approach to the structure determination of GPCRs. An engineered form of the receptor was created by splicing cytochrome b562 into the loop between helix five and six. This small protein acts as a handle that holds the slippery receptors together in the crystal lattice. In this illustration, one molecule in the crystal lattice is shown with the receptor in red and the small cytochrome in orange. A variety of lipid-like detergents (seen here in green) are also needed to glue together the membrane-spanning portions of the receptor.


Open and Shut Case

Two structures of the P2Y12 receptor, from PDB entries 4pxz and 4ntj, reveal surprisingly large motion in the effector binding site. The structure with an antagonist bound is quite open, and several of the loops surrounding the site are disordered, showing a lot of motion. When the agonist binds, however, the loops close around it, forming a tight enclosed pocket. To explore these two structures in more detail, the JSmol tab below displays an interactive JSmol.

P2Y Receptor (PDB entries 4pxy and 4ntj)

Two structures of the P2Y12 receptor are overlapped here. The structure with an antithrombotic drug, which acts as an antagonist that blocks the action of the receptor, is quite open and several of the effector-binding loops are disordered. The structure with a modified form of ADP, which acts as an agonist that activates the receptor, is closed around the ligand. Use the buttons to compare the two structures and change the representation.

References

  1. Zhang, K. et al. Structure of the human P2Y12 receptor in complex with an antithrombotic drug. Nature 509, 115-118 (2014).

  2. Zhang, J. et al. Agonist-bound structure of the human P2Y12 receptor. Nature 509, 119-122 (2014).

Structural Biology Knowledgebase ISSN: 1758-1338
Funded by a grant from the National Institute of General Medical Sciences of the National Institutes of Health